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Introduction
============

UV radiation (UVR) is a potent carcinogen that acts directly on DNA. Accumulated lifetime exposure to UVR is the key environmental risk factor for development of nonmelanoma skin cancers (NMSCs), such as basal and squamous cell carcinomas ([@bib14]). The cellular response to DNA damage is centered on p53, a transcription factor that exerts its tumor-suppressive function by inducing cell cycle arrest, cell senescence, or apoptosis ([@bib34]). The importance of p53 in the prevention of UVR-induced skin cancer is underscored by the observation that after chronic UV irradiation, p53-deficient mice exhibit a vastly increased incidence and reduced latency of NMSC compared with wild-type (wt) animals ([@bib16]). Programmed cell death initiated by UVR is required to remove precancerous keratinocytes, yielding so-called sunburn cells (SBCs). Their formation appears to represent a crucial tumor-suppressive response because they arise from the cell type of origin for NMSC and their development requires functional p53 ([@bib37]; [@bib16]).

Two distinct signaling pathways activate the caspases that mediate apoptosis ([@bib30]). The extrinsic pathway is initiated by "death receptors" (several members of the TNF-R family) and proceeds via caspase-8 and its adaptor FADD (Fas-associated death domain), whereas the intrinsic or mitochondrial pathway is regulated by the interacting pro- and antiapoptotic members of the Bcl-2 protein family and leads, after mitochondrial outer membrane permeabilization, to caspase-9 activation. Although UVR-induced apoptosis clearly involves the downstream effector caspases ([@bib15]), the relative roles of the extrinsic and intrinsic pathways are controversial. The extrinsic pathway is favored by evidence that membrane localization of the death receptors Fas (also called APO-1 or CD95) and TRAIL-R is up-regulated in a p53-dependent manner after UVR exposure ([@bib2]) and that UV-irradiated *gld/gld* (FasL-deficient) mice exhibit reduced SBC formation ([@bib10]). On the other hand, UV-irradiated mice overexpressing Bcl-2 in keratinocytes exhibited fewer SBCs and more skin tumors than control animals ([@bib25]).

In the intrinsic path to cell death, the key initiators are the BH3-only members of the Bcl-2 family ([@bib11]). Different death stimuli activate distinct subsets of these death ligands. For example, Noxa and Puma are up-regulated during p53-mediated cell killing, and their genes are direct p53 targets ([@bib21]; [@bib20]; [@bib36]). Gene-targeting experiments in mice have demonstrated that Puma plays a major and Noxa a more restricted role in p53-mediated apoptosis ([@bib13]; [@bib28]; [@bib33]). Primary mouse embryonic fibroblasts (MEFs) as well as E1A oncogene transformed MEFs from Puma-deficient animals proved refractory to etoposide, and *puma* ^−/−^ lymphoid and myeloid cells were remarkably resistant to genotoxic damage ([@bib13]; [@bib33]; [@bib7]). The role of Noxa has been less clear, as its loss gave MEFs only slight, albeit significant, resistance against etoposide and did not affect any apoptotic responses in lymphoid cells ([@bib28]; [@bib33]).

Here, we have sought to delineate the pathways to cell death elicited by UV irradiation of primary MEFs, the MEFs rendered more sensitive to genotoxic damage by transformation with the adenovirus E1A and *ras* oncogenes ([@bib18]) and keratinocytes within whole mouse skin. We demonstrate that the Bcl-2 family regulates not only the death induced by p53 but also a p53-independent pathway in response to UVR. By exploiting MEFs that lack different BH3-only proteins, we show that in primary cells, both Noxa and Puma contribute to UVR-induced apoptosis. Unexpectedly, only Noxa plays a major role in the transformed MEFs and keratinocytes, where the *noxa*, but not the *puma*, gene proved to be induced.

Results
=======

UV irradiation triggers both apoptotic and nonapoptotic cell death in primary MEFs but predominantly apoptosis in transformed MEFs
----------------------------------------------------------------------------------------------------------------------------------

To examine whether UV-irradiated MEFs die by apoptosis, several well-established parameters were assessed in both primary and E1A/*ras* transformed MEFs ([Fig. 1](#fig1){ref-type="fig"} and Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200608070/DC1>). Morphological and flow cytometric examination indicated that relatively few primary MEFs died when exposed to low-dose UVR (5--50 J/m^2^). Although they exhibited some morphological signs of apoptosis at these doses, at higher doses (e.g., 200 J/m^2^), they appeared to die predominantly by a nonapoptotic mechanism, as indicated by the prevalence of large, vacuolated cells at 6 h after irradiation ([Fig. 1 A](#fig1){ref-type="fig"}). In contrast, at both low and high doses, the MEFs sensitized to genotoxic damage by oncogenic transformation ([@bib18]) exhibited classical morphological signs of apoptosis, such as chromatin condensation and membrane blebbing ([Fig. 1 A](#fig1){ref-type="fig"}), as well as hallmark biochemical features. Notably, caspase activity was evident from the generation of the cleaved p12 and p85 fragments of the canonical caspase substrates ICAD (inhibitor of caspase-activated DNase) and PARP (poly ADP ribose polymerase), respectively (Fig. S1, A and B). The resulting release of the active DNase CAD from its inhibitor ICAD presumably accounts for the characteristic DNA fragmentation (Fig. S1 C) and the cell population with DNA content of \<2C (Fig. S1 D). Consistent with the different fates of primary and E1A/*ras* transformed MEFs, active caspase-3 increased in E1A/*ras* MEFs but not in primary MEFs ([Fig. 1 B](#fig1){ref-type="fig"}). Thus, although E1A/*ras* transformed MEFs are highly sensitive to UVR-induced apoptosis, primary MEFs are more resistant and die at high doses, predominantly by a nonapoptotic mechanism.

![**UVR induces apoptosis in E1A/*ras* transformed MEFs but predominantly nonapoptotic death in primary MEFs.** (A) Cytospin preparations of untreated cells or cells exposed to 200 J/m^2^ UVR were stained with hematoxylin and eosin. A higher magnification of E1A/*ras* transformed MEFs (middle) shows an enlarged necrotic cell (arrowhead) with large cytoplasmic vesicles. Apoptotic cells (asterisks) are identifiable by cell shrinkage, dark and punctate nuclear staining, and membrane blebbing. These figures are representative of two independent lines of primary and E1A/*ras* transformed MEFs from wt mice. Bars: (top middle) 25 μm; (others) 50 μm. (B) Western blot to reveal active caspase-3 in primary or E1A/*ras* transformed wt MEFs stimulated with 100 or 10 J/m^2^ UVR, respectively.](jcb1760415f01){#fig1}

Overexpression of Bcl-2 but not blockade of death receptor signaling inhibits UVR-induced apoptosis
---------------------------------------------------------------------------------------------------

To investigate whether the extrinsic or intrinsic signaling pathway drives UVR-induced apoptosis, two independently generated E1A/ras transformed wt MEF lines were transfected with expression vectors that encode Bcl-2 or proteins that inhibit the death receptor pathway: a well-characterized dominant-negative mutant of FADD (FADD-DN; [@bib5]) or the caspase-8 inhibitor CrmA ([@bib30]). Both inhibitors were expressed ([Fig. 2, B and D](#fig2){ref-type="fig"}) and functional, as they blocked the death of MEFs stimulated with FasL (not depicted). Nevertheless, neither FADD-DN nor CrmA notably inhibited UVR-induced apoptosis ([Fig. 2, A and C](#fig2){ref-type="fig"}). In striking contrast, Bcl-2 overexpression ([Fig. 2 E](#fig2){ref-type="fig"}) almost completely ablated UVR-induced cell death ([Fig. 2 C](#fig2){ref-type="fig"}). We conclude that the UVR-induced apoptosis of the transformed MEFs proceeds through the Bcl-2--regulated pathway.

![**UVR-induced apoptosis of transformed MEFs is inhibited by Bcl-2 overexpression but not by blockade of the death receptor pathway.** (A) E1A/*ras* transformed wt MEFs retrovirally transduced with a control vector or a construct encoding FLAG--FADD-DN were exposed to graded doses of UVR, and viability was analyzed at 24 h by PI staining. Data represent the mean ± SD of two independent lines. (B) Western blot analysis using anti-FLAG antibody was performed on lysates derived from FLAG--FADD-DN--expressing and control vector--infected cells. A band of the expected size (p16) was detected in FLAG--FADD-DN--expressing cells. β-Actin served as a loading control. (C) Transformed wt MEFs retrovirally transduced with a control vector, a construct encoding FLAG-tagged CrmA or Bcl-2, were exposed to graded doses of UVR, and viability was determined as in A. Data represents mean ± SD of two independent lines. (D) Western blot analysis using anti-FLAG antibody was performed on lysates derived from FLAG-CrmA--expressing and control vector--transfected cells, with β-actin as a loading control. (E) Intracellular FACS staining with a human Bcl-2--specific monoclonal antibody (Bcl-2-100).](jcb1760415f02){#fig2}

Loss of p53, Noxa, or Puma partially protects primary MEFs against UVR-induced cell death
-----------------------------------------------------------------------------------------

The strong protection conveyed by Bcl-2 ([Fig. 2 C](#fig2){ref-type="fig"}) prompted us to investigate which of its BH3-only antagonists drives this process. Primary MEFs derived from wt mice or those lacking Bim, Bad, Noxa, or Puma were exposed to graded doses of UVR, and cell viability was monitored 24 h later. Wt primary MEFs exhibited dose-dependent rates of death, which was just as extensive in MEFs lacking Bad or Bim (Fig. S2 A, available at <http://www.jcb.org/cgi/content/full/jcb.200608070/DC1>). In contrast, the cells lacking p53, Noxa, or Puma all displayed greater viability than wt controls at doses up to 50 J/m^2^ ([Fig. 3 A](#fig3){ref-type="fig"}).

![**Significant roles for p53, Noxa, and Puma in UVR-induced killing of primary MEFs.** (A) Primary MEFs from *p53* ^−/−^, *noxa* ^−/−^, or *puma* ^−/−^ embryos were exposed to graded doses of UVR, and cell survival was determined after 24 h. (B) UVR dose response of wt, *p53* ^−/−^, *noxa* ^−/−^, and *noxa* ^−/−^ *puma* ^−/−^ primary MEFs. By *t* test, *noxa* ^−/−^ *puma* ^−/−^ MEFs were significantly more resistant than *noxa* ^−/−^ MEFs to 100 J/m^2^ of UVR. \*, P \< 0.025. (C) Kinetics of cell survival for wt, *p53* ^−/−^, *noxa* ^−/−^, and *noxa* ^−/−^ *puma* ^−/−^ primary MEFs subjected to 25 J/m^2^ UVR. Results shown represent the mean percentage of viability ± SD of MEFs from three independent embryos of each genotype.](jcb1760415f03){#fig3}

Because many BH3-only proteins have partially redundant functions ([@bib11]), we also generated primary MEFs from mice lacking both Noxa and Puma, or Noxa and Bim. The primary *noxa* ^−/−^ *puma* ^−/−^ MEFs were significantly more resistant than *noxa* ^−/−^ cells at doses of 100 and 200 J/m^2^ ([Fig. 3 B](#fig3){ref-type="fig"}; P \< 0.025), although the slight increases at lower doses were not significant. Remarkably, at all doses and times analyzed, the primary *noxa* ^−/−^ *puma* ^−/−^ MEFs were at least as refractory to UVR as the *p53* ^−/−^ MEFs ([Figs. 3, B and C](#fig3){ref-type="fig"}), indicating that Noxa and Puma account for all p53-mediated killing of UV-irradiated primary MEFs. In contrast, the *noxa* ^−/−^ *bim* ^−/−^ primary MEFs were no more refractory than those lacking Noxa alone (Fig. S2 B). Thus, at doses up to 50 J/m^2^, the UVR-induced apoptosis of primary MEFs is driven mainly through p53 and its targets Noxa and Puma, whereas Bad and Bim are dispensable. At higher doses of UVR, the substantial killing of the *p53* ^−/−^, *noxa* ^−/−^, *puma* ^−/−^, and *noxa* ^−/−^ *puma* ^−/−^ MEFs ([Fig. 3 A](#fig3){ref-type="fig"}) probably reflects nonapoptotic cell death.

Loss of p53 or Noxa but not Puma renders transformed MEFs resistant to UVR-induced apoptosis
--------------------------------------------------------------------------------------------

To circumvent the complication of nonapoptotic UVR-induced cell death, we derived independent E1A/*ras* transformed MEFs from three embryos of various genotypes (wt, *p53* ^−/−^, *bim* ^−/−^, *noxa* ^−/−^, and *puma* ^−/−^ E1A/*ras* lines 1--3). Because the E1A oncoprotein sensitizes MEFs to apoptosis by inactivating the RB tumor suppressor, we verified by intracellular FACS analysis that all transformed lines of every genotype expressed similar levels of E1A (Fig. S3 A, available at <http://www.jcb.org/cgi/content/full/jcb.200608070/DC1>).

When the cell lines were subjected to UVR at 10--50 J/m^2^ and viability analyzed 24 h later, the p53-deficient E1A/*ras* MEFs were consistently the most resistant, and Noxa-deficient MEFs demonstrated a marked, albeit lower, level of resistance ([Fig. 4 A i](#fig4){ref-type="fig"} and Fig. S3). In contrast, loss of Bim conveyed no protection ([Fig. 4 A, i and ii](#fig4){ref-type="fig"}). Unlike the enhanced resistance in the *puma* ^−/−^ primary MEFs ([Fig. 3 A](#fig3){ref-type="fig"}), their transformed derivatives behaved like wt MEFs except for slightly greater viability at 10 and 20 J/m^2^ ([Fig. 4 A i](#fig4){ref-type="fig"}; P \< 0.025). To determine whether these protective effects persisted, viability was also analyzed at 24, 48, and 72 h after an intermediate dose of UVR (15 J/m^2^). The *bim* ^−/−^ and *puma* ^−/−^ cells died as rapidly as wt cells ([Fig. 4 A ii](#fig4){ref-type="fig"}). Indeed, even most of the cells deficient in p53 or Noxa had succumbed by 72 h after irradiation; only 15% of them remained viable, although this still greatly exceeded the 1% viability of the wt cells ([Fig. 4 A](#fig4){ref-type="fig"} ii). Thus, Noxa is the major initiator of UVR-induced apoptosis downstream of p53 in E1A/*ras* transformed MEFs.

![**Loss of p53 or Noxa protects E1A/*ras* transformed MEFs from UVR-induced apoptosis.** (A, i) UVR dose-response analysis of E1A/*ras* transformed MEFs harvested at 24 h after irradiation. \*, P \< 0.025. (ii) Kinetics of cell survival of E1A/*ras* transformed MEFs exposed to 15 J/m^2^ UVR. Data represent mean percentage of viability ± SD of three independent embryos (two embryos for *bim* ^−/−^ E1A/*ras* cells). (B, i) UVR dose response of E1A/*ras* transformed MEFs from *noxa* ^−/−^ *bim* ^−/−^ mice. (ii) Kinetics of cell survival of E1A/ras transformed *noxa* ^−/−^ *bim* ^−/−^ MEFs subjected to 15 J/m^2^ UVR. By *t* test, *noxa* ^−/−^ *bim* ^−/−^ MEFs were significantly more resistant than *noxa* ^−/−^ MEFs at 24 h after UVR stimulation. \*, P \< 0.05. (iii) UVR dose response of E1A/*ras* transformed *noxa* ^−/−^ *puma* ^−/−^ MEFs. Cell viability was determined at 24 h after UVR by PI staining and FACS analysis. (iv) Kinetics of cell survival of E1A/*ras* transformed *noxa* ^−/−^ *puma* ^−/−^ MEFs subjected to 15 J/m^2^ UVR. Results shown represent the mean percentage of viability ± SD of MEFs from three independent embryos of each genotype.](jcb1760415f04){#fig4}

Loss of Noxa plus Puma or Noxa plus Bim does not render transformed MEFs as resistant to UVR as p53 loss
--------------------------------------------------------------------------------------------------------

The observation that *noxa* ^−/−^ transformed MEFs were more sensitive to UVR than the corresponding *p53* ^−/−^ or Bcl-2 overexpressing cells suggested that Noxa is not the sole initiator of UVR-induced apoptosis. Because our studies suggested that Puma or Bim might have an auxiliary role, we generated transformed MEFs from *noxa* ^−/−^ *bim* ^−/−^ and *noxa* ^−/−^ *puma* ^−/−^ embryos. Dose-response analysis at 24 h after UVR indicated that the *noxa* ^−/−^ *bim* ^−/−^ transformed cells appeared to survive slightly better than *noxa* ^−/−^ MEFs at all doses tested ([Fig. 4 B](#fig4){ref-type="fig"} i) and had a small but significant advantage at 24 h after stimulation with 15 J/m^2^ ([Fig. 4 B](#fig4){ref-type="fig"} ii; P \< 0.05). Unexpectedly, the *noxa* ^−/−^ *puma* ^−/−^ transformed cells were no more resistant to UVR than counterparts deficient in Noxa alone ([Fig. 4 B](#fig4){ref-type="fig"}, iii and iv).

Puma mRNA is induced by UVR in primary but not E1A/ras transformed MEFs
-----------------------------------------------------------------------

To clarify why loss of either Noxa or Puma protected the primary MEFs ([Fig. 3 A](#fig3){ref-type="fig"}) but only loss of Noxa substantially protected the transformed MEFs ([Fig. 4 A](#fig4){ref-type="fig"}), we quantified *noxa* and *puma* transcripts by PCR at various times after treatment with UVR, or etoposide as a positive control, and normalized the values to unstimulated controls. In transformed MEFs, UVR induced *noxa* mRNA 2.3-fold but, surprisingly, slightly reduced the *puma* mRNA level ([Fig. 5 A](#fig5){ref-type="fig"}). The up-regulation of *noxa* mRNA was p53 dependent, as no increase occurred in *p53* ^−/−^ MEFs ([Fig. 5 A](#fig5){ref-type="fig"}, top). In contrast, etoposide up-regulated both *noxa* and *puma*, albeit *noxa* to a greater extent (∼11- vs. 4.5-fold). The absence of *puma* mRNA at 6 h after etoposide treatment indicates that this transcript is rapidly induced but then degraded ([Fig. 5 A](#fig5){ref-type="fig"}).

![***Puma* mRNA is up-regulated by UVR in primary but not E1A/*ras* transformed MEFs.** (A) Quantitative PCR analysis of *noxa* mRNA in E1A/*ras* transformed wt MEFs 6 h after treatment with 25 J/m^2^ UVR or 10 μg/ml etoposide. *Puma* mRNA levels were assessed in these MEFs at 2 and 4 h after treatment with 25 J/m^2^ UVR or 10 μg/ml etoposide. (B) *Noxa* and *puma* mRNA expression was assessed in wt primary MEFs after exposure to 25 or 100 J/m^2^ UVR or 100 μg/ml etoposide. Transcript abundance was normalized to levels observed in unstimulated control cells and represented as fold induction. Data shown represent the mean fold induction ± SD observed in MEFs from two independent wt embryos. SD is small where not visible. Dashed lines indicate a basal expression level of 1.](jcb1760415f05){#fig5}

In primary wt MEFs, UVR, like etoposide, induced both *noxa* and *puma* mRNA ([Fig. 5 B](#fig5){ref-type="fig"}). Interestingly, *puma* mRNA was up-regulated slightly more by a high dose (100 J/m^2^) than a low dose (25 J/m^2^) of UVR ([Fig. 5 B](#fig5){ref-type="fig"}, top right; 2.5- vs. 1.8-fold maximum at 2 h), whereas *noxa* mRNA exhibited the reciprocal pattern ([Fig. 5 B](#fig5){ref-type="fig"}, top left; 1.4- vs. 2.2-fold maximum at 4 h). These results show that UVR increases *puma* mRNA levels in primary but not in E1A/*ras* transformed MEFs and that UVR dose affects the relative abundance of *puma* and *noxa* transcripts in primary cells.

In hemopoietic progenitor cells, DNA damage induces the transcriptional repressor Slug, which in turn ablates the activation of *puma* by p53 ([@bib35]). To explore whether Slug or its close relative Snail might account for the absence of *puma* mRNA in UV-irradiated E1A/*ras* MEFs, we analyzed their activation profile by quantitative PCR. Snail mRNA levels were not affected by treatment with UVR or etoposide, in both the primary and transformed MEFs ([Fig. 6](#fig6){ref-type="fig"}, left). As we hypothesized, however, *slug* mRNA remained unchanged after irradiation of primary MEFs but was induced approximately threefold by UVR in wt E1A/*ras* MEFs ([Fig. 6 A](#fig6){ref-type="fig"}). This induction did not require p53, as *slug* mRNA was still up-regulated by UVR in *p53* ^−/−^ E1A/*ras* MEFs ([Fig. 6 B](#fig6){ref-type="fig"}). In contrast, etoposide-induced up-regulation of *slug* in wt E1A/*ras* MEFs requires p53, as *slug* remained at basal levels in stimulated *p53* ^−/−^ E1A/*ras* MEFs ([Fig. 6 B](#fig6){ref-type="fig"}). Thus, Slug may well be responsible for the absence of *puma* induction in UV-irradiated transformed MEFs (see Discussion).

![**The transcriptional repressor *slug* is constitutively expressed in E1A/*ras* transformed MEFs.** (A) Quantitative PCR analysis of *slug* and *snail* mRNA expression in wt primary and E1A/*ras* transformed MEFs. (B) Quantitative PCR analysis of *slug* and *snail* mRNA expression in *p53* ^−/−^ E1A/*ras* transformed MEFs. Data shown represent the mean fold induction ± SD of two independent cell lines, and dashed lines indicate the basal expression level.](jcb1760415f06){#fig6}

Bcl-2 overexpression increases the UVR resistance of transformed MEFs lacking Noxa, Puma, or even p53
-----------------------------------------------------------------------------------------------------

To investigate the mechanism of UVR-induced death that occurs in the absence of Noxa, Puma, or p53 ([Fig. 3 A](#fig3){ref-type="fig"}), human Bcl-2 was overexpressed in E1A/*ras* transformed MEFs from wt, *noxa* ^−/−^, *puma* ^−/−^, or *p53* ^−/−^ mice ([Fig. 7 B](#fig7){ref-type="fig"}). Remarkably, Bcl-2 overexpression not only enhanced resistance to UVR in wt MEFs ([Fig. 2 C](#fig2){ref-type="fig"}, right) but also in the MEFs lacking Noxa, Puma, or even p53 ([Fig. 7 A](#fig7){ref-type="fig"}). Indeed, in *puma* ^−/−^ MEFs exposed to 50 J/m^2^ UVR, Bcl-2 overexpression increased survival from \<5 to 70% and in *noxa* ^−/−^ or *p53* ^−/−^ cells, it saved ∼95% of the cells ([Fig. 7 A](#fig7){ref-type="fig"}). As a control, E1A/*ras* transformed *noxa* ^−/−^ MEFs were transfected with constructs encoding FADD-DN or CrmA, but neither of these inhibitors augmented resistance to UVR ([Fig. 7 C](#fig7){ref-type="fig"}). These results demonstrate that UVR-induced apoptosis must proceed via a Bcl-2--inhibitable pathway in addition to that orchestrated by p53 and its death effectors Noxa and Puma.

![**Bcl-2 overexpression further inhibits UVR-induced apoptosis in Noxa- or p53-deficient transformed MEFs.** (A) UVR dose-response analysis of E1A/*ras* transformed *noxa* ^−/−^, *p53* ^−/−^, and *puma* ^−/−^ MEFs transfected with a human Bcl-2--GFP (open circles) expression vector or a control GFP vector (closed circles). (B) Transgenic Bcl-2 expression levels, determined by intracellular immunofluorescent staining. The numerical values represent the mean fluorescence intensity of the cell populations. The unbroken line represents negative control (staining with FITC-conjugated secondary antibody only), and the dashed line represents staining with human anti--Bcl-2 antibody plus FITC-conjugated secondary antibody. (C) Cell viability of E1A/*ras* transformed *noxa* ^−/−^ MEFs transfected with either a FADD-DN or a CrmA retroviral expression construct, was assessed as described in [Fig. 2](#fig2){ref-type="fig"}. Closed circles indicate control, and open circles indicate FADD-DN--GFP or CrmA-GFP. Data in A and C represent the mean percentage of viability ± SD of MEFs from two independent embryos.](jcb1760415f07){#fig7}

Loss of p53 or Noxa suppresses the formation of SBCs in UV-irradiated mouse skin
--------------------------------------------------------------------------------

To extend these results to an in vivo context, we analyzed the induction of apoptosis in the skin of UV-irradiated mice of different genotypes, first by histology and enumeration of SBCs, identified by their eosinophilic cytoplasm, pyknotic nuclei, and detachment from surrounding cells ([Fig. 8 A](#fig8){ref-type="fig"}, arrowheads), and then by TUNEL staining (Fig. S4, available at <http://www.jcb.org/cgi/content/full/jcb.200608070/DC1>), to reveal cells undergoing DNA fragmentation. Unstimulated control skin from all genotypes ([Fig. 8 A](#fig8){ref-type="fig"}, left) exhibited well-ordered stratification of keratinocytes, an intact stratum corneum, and the absence of SBCs. UV-irradiated skin from p53- or Noxa-deficient animals exhibited a relatively preserved morphology and small numbers of SBCs ([Fig. 8](#fig8){ref-type="fig"}). In contrast, UV-irradiated skin from wt and *puma* ^−/−^ mice were hallmarked by large vacuoles, reduced epidermal thickness, loss of the stratum corneum, and an increased number of SBCs ([Fig. 8](#fig8){ref-type="fig"}). At 72 h after UVR, wt skin exhibited substantial parakeratosis, hyperkeratosis, keratinocyte loss, and dysplasia (Fig. S5). In contrast, there were only few parakeratotic and hyperkeratotic lesions in UV-irradiated *noxa* ^−/−^ and *p53* ^−/−^ skin at this time point, and these regions typically overlaid viable, well-ordered, and stratified keratinocytes (Fig. S5). Moreover, unstimulated control skin of each genotype displayed very few TUNEL-positive cells (Fig. S4). After stimulation with 1,000 J/m^2^ UVR, many more became evident in wt and *puma* ^−/−^ skin at 24 h, whereas considerably fewer arose in UV-irradiated skin from the *p53* ^−/−^, *noxa* ^−/−^, or *noxa* ^−/−^ *puma* ^−/−^ animals (Fig. S4). These data indicate that, although loss of Puma provided no protection, the loss of p53 or Noxa significantly reduced the number of apoptotic keratinocytes within the epidermal layer ([Fig. 8 B](#fig8){ref-type="fig"}; P \< 0.025).

![**Epidermal keratinocytes are protected from UVR-induced apoptosis by the loss of p53 or Noxa.** (A, left) Representative hematoxylin- and eosin-stained sections of nonirradiated skin of the indicated genotypes. (right) Representative sections of skin irradiated with 1,000 J/m^2^ UVR. Sc, stratum corneum; ep, epidermis; der, dermis; hf, hair follicle. Dashed lines delineate the epidermal--dermal junction. Arrowheads indicate the presence of SBCs. Bars, 100 μm. (B) Quantification of SBCs per linear centimeter of skin. The data represent the mean numbers ± SD from three to five mice of each genotype. The differences between UVR-treated wt and *p53* ^−/−^ and wt and *noxa* ^−/−^ mice are statistically significant (P \< 0.025). The difference between UVR-treated *noxa* ^−/−^ and *p53* ^−/−^ is also statistically significant (P \< 0.05).](jcb1760415f08){#fig8}

Up-regulation of *noxa* mRNA in UV-irradiated whole mouse skin
--------------------------------------------------------------

Quantitative PCR analysis revealed that the mRNA expression profiles of *noxa* and *puma* observed in cultured MEFs held for irradiated whole mouse skin. In wt skin, *noxa* mRNA was up-regulated approximately sevenfold and *puma* mRNA approximately twofold at 24 h after exposure to 1,000 J/m^2^ UVR ([Fig. 9 A](#fig9){ref-type="fig"}). As expected, the up-regulation of *noxa* mRNA at this time is mediated by p53, as there was no corresponding increase in the skin of *p53* ^−/−^ mice ([Fig. 9 B](#fig9){ref-type="fig"}).

![***Noxa* mRNA is up-regulated by UV irradiation in whole mouse skin.** (A) Quantitative PCR analysis of the kinetics of *noxa* and *puma* mRNA up-regulation in UV-irradiated skin of wt animals. (B) *Noxa* and *puma* mRNA expression at 24 h after irradiation in skin of wt and *p53* ^−/−^ animals.](jcb1760415f09){#fig9}

Discussion
==========

The death receptor pathway is dispensable for UVR-induced apoptosis of transformed MEFs
---------------------------------------------------------------------------------------

To determine whether cell surface--bound death receptors, such as Fas (Apo-1/CD95) or TNF-R1, are required for UVR-induced apoptosis, potent inhibitors of the extrinsic pathway, namely, FADD-DN and the caspase-8 inhibitor CrmA, were expressed in the transformed MEFs. As neither blocked the UVR-induced apoptosis, the death receptor pathway appears to be dispensable in these cells. Other reports, however, have implicated Fas signaling in cellular responses to UVR, such as immune suppression ([@bib29]). Furthermore, cell surface expression of Fas was shown to be up-regulated by p53 after UVR exposure ([@bib2]). However, in agreement with our findings, UVR-induced apoptosis of primary MEFs and keratinocytes did not require the critical death receptor mediator caspase-8 ([@bib32]; [@bib31]). How can the dispensability of death receptor signaling for UVR-induced apoptosis of keratinocytes be reconciled with the suppression of SBC formation in the skin of UV-irradiated FasL- deficient (C3H/HeJ *gld/gld*) mice ([@bib10])? One possible explanation is that death receptor signaling amplifies rather than initiates UVR-induced apoptosis. Alternatively, FasL-Fas signaling in the skin may represent a non--cell autonomous process, whereby FasL on leukocytes recruited by inflammatory cytokines engages Fas on UVR-damaged keratinocytes.

BH3-only proteins Noxa and, to a lesser extent, Puma initiate UVR-induced apoptosis downstream of p53
-----------------------------------------------------------------------------------------------------

The strong inhibition of UVR-induced apoptosis by Bcl-2 overexpression implicated proapoptotic members of this family in initiating the response. Indeed, both Noxa and Puma, BH3-only proteins previously associated with commitment to γ-irradiation--induced apoptosis, proved to play critical roles. Primary MEFs lacking either Noxa or Puma exhibited substantial resistance to doses up to 50 J/m^2^, although little protection was evident at higher doses, where nonapoptotic death appeared to predominate. Significantly, primary MEFs lacking both Noxa and Puma proved as refractory as those lacking p53 at all doses and times studied. This finding suggests that, in these cells, Noxa and Puma are the essential mediators of all p53-induced death after UV irradiation.

Although primary MEFs lacking Bim were not resistant to UVR-induced apoptosis, a minor role for Bim appeared in the transformed *noxa* ^−/−^ *bim* ^−/−^ MEFs, which exhibited a small but statistically significant survival advantage over transformed *noxa* ^−/−^ MEFs. Because DNA damage is not believed to induce *bim* mRNA and because UVR also causes cytoplasmic damage, cytoskeletal alterations provoking Bim release ([@bib23]) may occur independent of the DNA damage response. In any case, the function of Bim in the UVR response probably overlaps that of BH3-only proteins that play a more prominent role, such as Noxa. Noxa alone is a weak inducer of apoptosis, because it predominantly neutralizes Mcl-1 and robust cell killing requires additional BH3-only proteins, such as Bim or Puma, which can neutralize other prosurvival members ([@bib4]).

After UV irradiation, the transformed *noxa* ^−/−^ cells died at a rate intermediate between *p53* ^−/−^ and wt counterparts. Because both Noxa and Puma are up-regulated in a p53-dependent manner in response to DNA damage in many cell types ([@bib21]; [@bib20]; [@bib36]), it was surprising that, although the *noxa* ^−/−^ *puma* ^−/−^ primary MEFs survived high-dose UVR (100 or 200 J/m^2^) considerably better than *noxa* ^−/−^ MEFs, the transformed *noxa* ^−/−^ *puma* ^−/−^ MEFs showed no greater resistance to UVR than *noxa* ^−/−^ counterparts, at any dose or time examined. Examination of *puma* expression revealed that transformation ablated *puma* mRNA induction specifically in response to UVR. Because etoposide induced *puma* expression comparably in the primary and transformed MEFs, the *puma* suppression is probably mediated by a UVR-induced signal acting parallel to p53 rather than by the p53 pathway itself.

A precedent for failure of *puma* induction in the face of DNA damage and active p53 emerged with the discovery that in γ-irradiated hematopoietic progenitors, *puma* expression is silenced downstream of p53 by the transcriptional repressor Slug ([@bib35]). Indeed, we found that in E1A/*ras* transformed MEFs, but not in primary MEFs, UVR induces transcription of Slug, which may well be responsible for the failure of p53 to induce *puma* expression in these cells. However, in contrast to the hematopoietic progenitors, *slug* was up-regulated in the transformed MEFs irrespective of whether p53 was present.

Although we show that Noxa is the principal initiator of UVR-induced apoptosis, Puma is the principal initiator of apoptosis downstream of p53 activated by other genotoxic stimuli ([@bib13]; [@bib33]). For example, loss of Noxa did not protect lymphoid cells from any apoptotic stimulus tested and offered only minor protection to MEFs exposed to etoposide or γ-irradiation ([@bib28]; [@bib33]), whereas the corresponding *puma* ^−/−^ cells were markedly resistant ([@bib13]; [@bib33]). This difference probably reflects the fact that UVR produces pyrimidine dimers, whereas γ-irradiation and etoposide produce double-strand breaks in DNA. Although all genotoxic damage leads to p53 stabilization, the activity of p53 can be altered by the different kinases (e.g., ATM and ATR) selectively activated by these two types of DNA damage ([@bib19]; [@bib1]). A plausible model is that the levels and/or activity of Noxa and Puma are modulated selectively by different posttranslationally modified forms of p53 and possibly also by p53-independent signals ([Fig. 10 A](#fig10){ref-type="fig"}, X or Y) that are determined by the nature of the DNA damage.

![**Model for the control of Noxa and Puma expression during DNA damage--induced apoptosis.** (A) Model to explain why UVR-induced DNA damage triggers apoptosis in E1A/*ras* transformed MEFs predominantly via Noxa, whereas Puma predominates for apoptosis triggered by etoposide-induced DNA damage. X and Y represent distinct signaling pathways activated in parallel to the p53 pathway by the two different forms of DNA damage. (B) An integrated model of UVR-induced apoptosis. In addition to the p53-dependent pathway activated through Noxa and Puma, a p53-independent pathway to neutralization of antiapoptotic Bcl-2--like proteins is postulated, based on the finding that Bcl-2 overexpression provided *p53* ^−/−^ E1A/*ras* transformed MEFs with additional protection from UVR. This pathway (Z) may involve both transcriptional and posttranslational mechanisms of regulating pro- and antiapoptotic members of the Bcl-2 family.](jcb1760415f10){#fig10}

Bcl-2 overexpression increases the resistance of *p53* ^−/−^ cells to UVR
-------------------------------------------------------------------------

Despite their enhanced resistance to UVR, a substantial proportion of *noxa* ^−/−^ and, remarkably, even *p53* ^−/−^ cells still died after irradiation. The failure of FADD-DN or CrmA to inhibit the death of Noxa-deficient cells demonstrates that their UVR-induced apoptosis does not require death receptor signaling. In contrast, the substantial protection conveyed by Bcl-2 overexpression, even in the absence of p53, demonstrates that UV irradiation can trigger at least two distinct pathways to apoptosis. One of these pathways leads via p53 to induction of *noxa* and *puma*, whereas the other activates a Bcl-2--inhibitable apoptosis inducer via a p53-independent route ([Fig. 10 B](#fig10){ref-type="fig"}, Z).

What molecular mechanisms might mediate this p53-independent but Bcl-2--inhibitable pathway to UVR-induced cell death? Transformation by E1A may well have activated this pathway. By antagonizing RB, the E1A in the transformed MEFs deregulates E2F activity, including that of E2F1 ([@bib27]), which can enhance expression of several BH3-only proteins ([@bib9]) and repress that of Mcl-1 ([@bib6]). Another interesting candidate is the JNK signaling pathway. In response to UVR, the JNKs phosphorylate diverse nuclear and cytoplasmic substrates, including c-Jun, a constituent of the transcription factor AP-1 that is rapidly induced upon UVR exposure ([@bib17]). Notably, *Jnk1* ^−/−^ *Jnk2* ^−/−^ MEFs ([@bib31]) and c-Jun--deficient fibroblasts ([@bib26]) are abnormally resistant to UVR.

Loss of p53 or Noxa protects keratinocytes from apoptosis induced by UV irradiation
-----------------------------------------------------------------------------------

To extend our in vitro findings to a relevant physiological context, we UV irradiated the skin of wt, *p53* ^−/−^, *noxa* ^−/−^, *puma* ^−/−^, and *noxa* ^−/−^ *puma* ^−/−^ mice. Consistent with previous findings ([@bib37]), UV-irradiated *p53* ^−/−^ animals exhibited significantly fewer SBCs than wt controls at 24 h after irradiation, and the extent of SBC formation in *noxa* ^−/−^ skin was comparable to that in *p53* ^−/−^ skin. In contrast, the extent of SBC formation in *puma* ^−/−^ skin was indistinguishable from wt controls. Even at 72 h after UVR, there was enhanced survival of keratinocytes in *p53* ^−/−^ and *noxa* ^−/−^ skin, demonstrating that loss of p53 or Noxa provided longer term protection and not only a delay in apoptosis. The greater role of Noxa in the skin may be related to our finding that *noxa* was increased approximately sevenfold and *puma* only approximately twofold at 24 h after irradiation. p53 protein is strongly up-regulated in UV-irradiated skin from 2 to 24 h after exposure ([@bib8]), and accordingly, the robust induction of Noxa at 24 h required p53.

In summary, our analyses of two different cell line systems and the skin of intact mice identify Noxa as the principal mediator of UVR-induced apoptosis. Furthermore, we provide evidence of a pathway that collaborates with the p53 pathway to activate *noxa*, plus the activation of a p53- and Noxa-independent pathway to apoptosis that can be blocked by Bcl-2. The delineation of these pathways will provide insight into how the stimulus specificity of BH3-only protein activation is conferred downstream of p53.

Materials and methods
=====================

Mice
----

All experiments with animals were conducted according to the guidelines of the Melbourne Research Directorate Animals Ethics Committee. The generation of *puma* ^−/−^ ([@bib33]), *noxa* ^−/−^ ([@bib33]), *bim* ^−/−^ ([@bib3]), *bad* ^−/−^ ([@bib24]), and *p53* ^−/−^ mice ([@bib12]) has been described. The *puma* ^−/−^ and *noxa* ^−/−^ mice were generated on an inbred C57BL/6 background using C57BL/6-derived embryonic stem cells, whereas *bim* ^−/−^, *bad* ^−/−^, and *p53* ^−*/*−^ mice were produced on a mixed C57BL/6 × 129Sv background using 129Sv-derived embryonic stem cells and were backcrossed with C57BL/6 mice for \>10 generations. MEFs were derived from day 14.5 embryos and were cultured to ∼80% confluence before passage 1 (P1).

Whole skin UV irradiation, histological analysis, and microscopic imaging
-------------------------------------------------------------------------

A depilated region of dorsal skin was exposed to UVR supplied by a bank of six UVB lamps (FL20SE; Heraeus Amba Lamps). Spectral output was quantified with a radiometer (model IL1400A) fitted with a detector (SEL240; International Light).

All microscopy used either a Stemi SV11 (Carl Zeiss MicroImaging, Inc.) or a microscope (Axioplan 2; Carl Zeiss MicroImaging, Inc.). The latter used objective lenses (5×/NA 0.15 and 10×/NA 0.30). Images were recorded with a camera (AxioCam) and AxioVision software (Carl Zeiss MicroImaging, Inc.).

Generation of stably transformed cell lines
-------------------------------------------

The Phoenix packaging line was used to produce high-titre, replication-incompetent retrovirus using the Fugene 6 Transfection method (Roche). In brief, Phoenix cells were transfected with plasmid DNA (pWZLH.12S \[E1A\] and pBabePuro.H-Ras; gifts from M. Schuler, Johannes Gutenberg University, Mainz, Germany; D. Green, St. Jude Children\'s Research Hospital, Memphis, TN; and S. Lowe, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY). Primary MEFs were infected by centrifugation for 45 min at 32°C in the presence of viral supernatant. This process was performed on 2 consecutive days, and transfected cells were selected by incubation with 3 μg/ml puromycin and 100 μg/ml hygromycin B (Invitrogen) for at least 1 wk. FLAG--FADD-DN and FLAG-CrmA DNA sequences were subcloned into the MSCV-IRES-GFP vector backbone to generate retroviral expression constructs ([@bib22]). GFP-labeled cells were sorted using a FACStar cell sorter (Becton Dickinson) to obtain an 85--90% GFP^+^ population.

Cell culture and viability assays
---------------------------------

Early passage (P2) primary MEFs and E1A/*ras* transformed MEFs were maintained in a high-glucose DME supplemented with 10% fetal calf serum, 10^−6^ M asparagine, and 50 μM 2-mercaptoethanol. Cells were seeded at 2.5 × 10^5^ per well (6-well tissue culture plate) and cultured to ∼60--70% confluency before irradiation with UVC (UV lamp; Sankyo Denki). UVR output was quantified with a Spectroline Shortwave (254 nm) Ultraviolet meter. Cells were stimulated for 48 h with 100 ng/ml recombinant human FasL (FLAG-tagged; Qbiogene) cross-linked with 1 μg/ml anti-FLAG M2 monoclonal antibody (Sigma-Aldrich).

To assess cell viability, both floating and adherent cells were harvested, stained with 0.5 μg/ml propidium iodide (PI), and analyzed in a FACScan (Becton Dickinson). Forward and side light scatter parameters were used to exclude debris and cell viability calculated in comparison to a negative control (no PI staining).

Biochemical and morphological analyses
--------------------------------------

Cells were washed twice with ice-cold PBS before lysis with Onyx lysis buffer (20 mM Tris-HCl, pH 7.4, 135 mM NaCl, 1.5 mM MgCl~2~, 1 mM EDTA, 1% Triton X-100, 10% glycerol, 2 mM sodium orthovanadate, 50 mM sodium fluoride, 1 μg/ml pepstatin, 1 μg/ml aprotinin, and 1 μg/ml leupeptin). 20 μg of total protein per sample were separated by gel electrophoresis (Tris-glycine Novex Pre-cast gels; Invitrogen) and transferred to nitrocellulose membranes (Hybond-C extra; GE Healthcare). Membranes were probed with antibodies to poly ADP ribose polymerase (Qbiogene), β-actin (Sigma-Aldrich), HSP70 (a gift from R. Anderson, Peter MacCallum Cancer Centre, East Melbourne, Australia), FLAG epitope tag (a gift from L. O\'Reilly and D. Huang, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia), ICAD (BD Biosciences), active caspase-3 (a gift from Y. Lazebnik, Cold Spring Harbor Laboratory), and Bim (clone 3C5; Qbiogene) and visualized using the ECL Western detection kit (GE Healthcare). Cytospin preparations (1 × 10^5^ and 1 × 10^4^ cells) were fixed in ice-cold methanol and stained with hematoxylin and eosin.

Quantitative PCR
----------------

Total RNA was extracted from ∼1 × 10^6^ cells or ∼100 mg of whole mouse skin using Trizol (Invitrogen) and treated with DNase I (Promega). First-strand cDNA synthesis was performed using 5 μg total RNA, SuperScript II reverse transcriptase (Invitrogen), and oligo(dT)~15~ primer (Promega) according to the manufacturer\'s instructions. One tenth of the reverse-transcription reaction was subjected to quantitative PCR using Quantitect SYBR Green PCR Master Mix (QIAGEN) in 10-μl reaction volumes and the ABI PRISM system (Applied Biosystems). β-Actin was used as an internal control, and basal transcript levels were estimated from cDNA samples from *puma* ^−/−^ and *noxa* ^−/−^ cells.

Statistics
----------

For statistical comparison, a *t* test was used, with P values \<0.05 considered significant.

Online supplemental material
----------------------------

The supplemental text discusses DNA fragmentation assay, cytochrome *c* release assay, TUNEL staining, and confocal microscopy. Fig. S1 shows hallmarks of apoptosis in E1A/*ras* transformed MEFs. Fig. S2 shows viability analyses of *bim* ^−/−^, *bad* ^−/−^, and *noxa* ^−/−^ *bim* ^−/−^ primary MEFs. In Fig. S3, intracellular immunofluorescent staining demonstrates that all E1A/*ras* transformed cell lines express E1A comparably and that cyctochrome *c* release after UV irradiation is abrogated by the loss of Noxa and p53. In Fig. S4, TUNEL analysis confirms the induction of apoptotic cell death in UV-irradiated epidermal keratinocytes. In Fig. S5, analysis of skin at 72 h after UV irradiation demonstrates the long-term protection afforded by the loss of Noxa or p53. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200608070/DC1>.
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